Product Pathways
BCP0157 Prasugrel
Prasugrel is a novel platelet inhibitor used for the reduction of thrombotic cardiovascular events (including stent thrombosis) in patients with acute coronary syndrome who are to be managed with PCI.
BCP000807 MRS2578
Selective antagonist of P2Y6 nucleotide receptors; IC50 values are 37 and 98 nM at human and rat P2Y6 receptors respectively
BCP000819 Prasugrel
BCP000939 KN62
KN62 ,CaM kinase II inhibitor. P2X7 antagonist.Cell-permeable, reversible and selective inhibitor of CaM kinase II (IC50 = 500 nM). Interacts with the calmodulin binding site of the enzyme. At higher concentrations reported to inhibit GSK3?, PRAK and MAPKAP-K2. Also potent non-competitive antagonist at the P2X7 receptor (IC50 = 15 nM).
BCP001066 GW791343 hydrochloride
BCP001067 Meclizine dihydrochloride
BCP001068 Ticlopidine hydrochloride
BCP001292 NF279
BCP0006995 A-740003
Potent, selective and competitive P2X7 receptor antagonist (IC50 values are 18 and 40 nM for rat and human receptors respectively).
第一页 1 最后页 
Only for research purpose , not for human consumption Copyright©2012 ShangHai Biochempartner Co.,Ltd.